Engflag

Tenoretic 50

Quick links to important sections

Tenoretic 50

Tenoretic 50_PL

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tenoretic 50

Property Description
Active Ingredients Atenolol and Chlortalidone
Form Oral Tablet
Pharmacological Class Antihypertensive Agent
Drug Type Fixed-Dose Combination (FDC)
Origin Synthetic Compounds

What is Tenoretic 50 and Its Pharmacological Identity?

Tenoretic 50 is a Fixed-Dose Combination (FDC) drug available only by prescription, primarily used for the management of hypertension, or high blood pressure. This medicine combines two distinct, synthetic agents, Atenolol and Chlortalidone, into a single oral tablet. This configuration classifies it as an Antihypertensive Agent, offering a synergistic approach to controlling elevated pressure. As a fixed-dose combination, it is designed for therapeutic benefit by achieving a blood pressure-lowering effect superior to that of either single ingredient used alone, providing a streamlined treatment option typically for adult patients requiring combination therapy.

Active Ingredients: Atenolol (Beta-Blocker) and Chlortalidone (Diuretic)

The components of Tenoretic 50 belong to two critical pharmacological classes: Atenolol is a cardioselective beta-blocker, and Chlortalidone is a thiazide-like diuretic. The number "50" in the name specifies the dosage of the Atenolol component (50 milligrams) in this particular tablet strength. Atenolol acts by regulating heart activity, while Chlortalidone acts on the body's fluid balance. Thiazide-type diuretics, such as Chlortalidone, serve as a foundational pharmacological approach for managing cardiovascular risk associated with hypertension, making the diuretic component a key part of blood pressure management.

How the Combination Provides General Therapeutic Benefit

  • The drug's effectiveness against hypertension relies on the combined action of its two components. This dual approach ensures that blood pressure is lowered by reducing the heart's workload (via Atenolol) and simultaneously decreasing the circulating fluid volume (via Chlortalidone).
  • This complementary action provides a stable, more pronounced blood pressure-lowering effect than either single agent could typically provide alone, supporting the overall goal of hypertension control. Tenoretic 50 is specifically differentiated by combining a hydrophilic beta-blocker (Atenolol) with a longer-acting diuretic (Chlortalidone), which contributes to its once-daily administration profile.

Regulatory References

  1. National Library of Medicine
  2. NIH/NLM

What side effects are possible with Tenoretic 50?

Tenoretic 50’s official safety profile is a composite of the officially documented adverse reactions associated with its two components: the beta-blocker Atenolol and the diuretic Chlortalidone. All adverse reactions are formally classified by System-Organ Class (SOC) and quantified by Frequency Classification in regulatory documents.

Documented Adverse Reactions

The most frequently reported adverse reactions, classified as Common in regulatory documents, include fatigue, lethargy, and bradycardia (slowed heart rate) from Atenolol, alongside electrolyte disturbances such as hypokalaemia (low potassium) and hyperglycaemia (high blood sugar) associated with Chlortalidone. Less common effects may include sleep disturbances, dry eyes, and paraesthesia.

Serious Adverse Reactions and Restrictions

Regulatory labels document specific, clinically significant reactions classified as Rare or Very Rare. These include Severe Bradycardia, the potential worsening of pre-existing heart failure, and serious blood disorders such as Agranulocytosis or severe skin reactions like Toxic Epidermal Necrolysis (TEN).

Absolute Contraindications are also specified in the regulatory information, prohibiting the drug's use in individuals with conditions such as Overt Heart Failure, Second or Third-Degree Heart Block, Anuria (absence of urine production), and Severe Renal or Hepatic Impairment.

Population-Specific Safety Notes

The safety profile includes specific considerations for certain patient groups, as defined in official labeling. Older Adults may be at an increased risk of adverse effects, particularly orthostatic hypotension and electrolyte imbalances. In patients with Diabetes, the Atenolol component may officially mask the physical signs of acute hypoglycemia, while Chlortalidone can necessitate adjustment of blood sugar control medication due to the risk of hyperglycemia. Long-term exposure to the diuretic component may require monitoring for electrolyte status.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Tenoretic 50 (Atenolol and Chlorthalidone) may result in severe, potentially life-threatening physiological manifestations that require immediate medical attention. Officially documented signs of overdose often involve profound cardiac and respiratory depression. These include severe bradycardia (abnormally slow heart rate), marked hypotension (dangerously low blood pressure), bronchospasm, and potentially a sinus pause or wheezing. Less severe but documented effects include lethargy, dizziness, general weakness, and nausea.

The combined action of the two agents can escalate to severe outcomes such as Second- or Third-Degree Heart Block, deterioration into Congestive Heart Failure, and cardiogenic shock. The diuretic component contributes to critical metabolic and fluid imbalances, leading to hypoglycemia, metabolic acidosis, and electrolyte disturbances. In patients with existing hepatic impairment, these changes carry the documented risk of precipitating hepatic coma.

Emergency Action is Mandatory

Regulatory authorities mandate that emergency medical attention must be sought immediately upon suspected overdose. Urgent medical help is specifically required if severe symptoms like fainting or profound trouble breathing occur. Management is symptomatic and supportive, as no specific antidote is known. Documented supportive procedures include physical removal of the unabsorbed drug using gastric lavage or administration of activated charcoal, with hemodialysis noted for the atenolol component.

Therapeutic Uses of Tenoretic 50

What Tenoretic 50 Treats: Main Uses and Benefits

Tenoretic 50 is commonly used across conditions presenting with acute episodes of elevated blood pressure, and is considered relevant in contexts involving heightened systemic burden. This medication is indicated for the treatment of hypertension (high blood pressure).

Providing Support for Symptom Management

This medication is applied across domains where additional symptomatic support is needed in contexts involving heightened systemic burden. It helps address symptom clusters that may become intense or disruptive, often used when symptoms intensify and supportive relief is needed. This supportive approach may help patients cope more steadily with symptom fluctuations when symptoms that create noticeable physiological strain become more noticeable.

It is used for managing the symptoms linked to systemic imbalance and supports the patient during difficult episodes.

Quick Fact: Relief for Physiological Strain

Tenoretic 50 may assist with addressing conditions marked by increased physiological stress, supporting general well-being during symptomatic phases.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Tenoretic 50 — Official Regulatory Information

The information below is based strictly on the population eligibility and contraindication sections of government-approved regulatory documents.

Eligibility Scope

Category Regulatory Status
Populations for whom use is allowed Adult patients with hypertension requiring fixed-dose combination therapy.
Populations for whom use is not recommended Pediatric patients (safety and efficacy not established); not for initial therapy of hypertension.
Populations for whom use is contraindicated Patients with Sinus Bradycardia, Heart Block greater than first degree, Cardiogenic Shock, Overt Cardiac Failure, Anuria, or Hypersensitivity to the drug or sulfonamide-derived drugs.
Pregnancy and lactation eligibility Contraindicated in pregnancy (associated with fetal injury). Use during lactation requires caution.
Eligibility-related restrictions Mandatory dosage adjustment is required for severe renal impairment. Caution is required in cases of impaired hepatic function or diabetes mellitus.

Eligibility Classifications (High-Level)

  • Eligibility severity classification (as defined in official documents): Contraindicated (Absolute Prohibition), Restricted/Conditional Use, Use Not Established.
  • Regulatory basis: FDA Prescribing Information / NIH DailyMed / Health Canada Product Monograph / UK SmPC.
  • Eligibility-context constraints (as defined in official documents): Cardiovascular function, excretory function, allergic status, and reproductive status.

Connection to the overall eligibility profile (2–4 sentences): Regulatory documents strictly define who can and cannot use this medicine by establishing formal contraindications based on severe pre-existing cardiac conditions (e.g., overt cardiac failure) and excretory status (anuria). Furthermore, eligibility is formally restricted by age, as safety is not established in children, and by physiological status, with use contraindicated in pregnancy and requiring mandatory adjustment for impaired renal function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Tenoretic 50, a combination of Atenolol and Chlorthalidone, defines specific interaction patterns primarily based on pharmacodynamic and pharmacokinetic effects. These patterns establish mandatory restrictions for safe co-administration.

Official Interaction Restrictions and Classifications

Interaction Type Interacting Substances / Restrictions
Contraindicated Combinations The combination with Verapamil or Diltiazem is contraindicated if administered intravenously within 48 hours of discontinuing the other agent.
Timing-Based Rules Clonidine withdrawal must be preceded by the withdrawal of Atenolol by several days. Separation of administration times by at least 2 hours may be advised for Multivitamin with Minerals to maintain exposure.
Exposure Modification Co-administration with Lithium may reduce its renal clearance, increasing serum concentrations. Administration with Orange Juice may decrease the bioavailability of the Atenolol component.
Additive Pharmacodynamic Effects Use with Digitalis Glycosides or certain Antiarrhythmic Agents increases the risk of bradycardia. Use with Prostaglandin Synthetase Inhibiting Drugs (NSAIDs) may officially decrease the blood pressure-lowering effects.

Connection to the Official Interaction Profile

Regulatory documents structure the product's interaction profile around mitigating two primary risks: managing additive effects on heart function and controlling for altered drug exposure. This framework formally mandates specific sequencing and separation rules to prevent documented, clinically significant interaction risks when co-administering certain agents.

Mechanism of Action

How Tenoretic 50 Works — The Mechanism of Action

The mechanism of Tenoretic 50 is based on the simultaneous, complementary actions of its two components, Atenolol and Chlorthalidone, to influence two major systems that regulate arterial pressure.

1. Modulation of Cardiac Output and Renin Release

This mechanistic domain centers on Atenolol's action as an antagonist at the Beta-1 (beta1) Adrenergic Receptors in the heart and kidneys. By blocking the effects of Norepinephrine at the cardiac beta1 receptors, the drug reduces the heart rate and the force of contraction, leading to a reduced Cardiac Output. In the kidneys, beta1 blockade suppresses the release of Renin, thus modulating the activity of the Renin-Angiotensin-Aldosterone System (RAAS).

2. Reduction of Volume and Vascular Resistance

This domain is driven by Chlorthalidone's function as an inhibitor of the Sodium-Chloride Cotransporter (NCC) in the kidney's distal convoluted tubule. This inhibition prevents the reabsorption of Na^+ and Cl^-, causing increased urinary excretion of salt and water (diuresis). The resulting physiological effect is a reduction in total Extracellular Fluid Volume. Chronic action of this mechanism leads to a decrease in tension and Systemic Vascular Resistance in the peripheral blood vessels.

3. Synergy via Counter-Regulation Neutralization

The combination produces a comprehensive physiological effect because the Atenolol component mechanistically counteracts the body's natural response to volume loss. Diuresis (from Chlorthalidone) typically triggers an increase in Renin release; Atenolol's suppression of Renin release modulates this hormonal feedback loop, leading to a coordinated reduction in the pressure load on the arteries.

Dosage and Administration Information

How to Use Tenoretic 50

This section outlines the general administration parameters for Tenoretic 50. The Fixed-Dose Combination (FDC) is available as an oral tablet in strengths of 50 mg / 25 mg (Atenolol/Chlorthalidone) and 100 mg / 25 mg.

Official Administration Protocol

Instruction Detail
Route of Administration Oral.
Dosing Schedule Once daily. The typical maximum daily dose is the 100 mg / 25 mg strength.
Preparation The tablet must be swallowed whole with a sufficient amount of liquid.
Use Context Constraint The FDC is not indicated for initial therapy of hypertension; it is reserved for substitution once individual component dose requirements align with the fixed ratio.

Procedural and Population Rules

Administration of Tenoretic 50 follows specific procedural and population parameters.

Instruction Detail
Renal Impairment Dose reductions are required when creatinine clearance (CrCl) falls below 35 mL/ min/ 1.73 m^2. For severe impairment (CrCl <15 mL/ min/ 1.73 m^2), the Atenolol component maximum is limited to 50 mg every other day.
Discontinuation Therapy is gradually reduced over a period of approximately one to two weeks; abrupt cessation is avoided.
Pediatric Use Use is generally not recommended as safety and efficacy have not been established in children.

These parameters define a standardized protocol that involves a specific approach to initiation, a continuous daily administration, and a gradual withdrawal process, all within established clinical limits.

Recent Clinical Evidence

Recent Clinical Evidence Overview

Tenoretic 50 is a fixed-dose combination medication containing the beta-blocker atenolol (50 mg) and the diuretic chlorthalidone (25 mg). The primary body of evidence supporting its use focuses on its role in treating hypertension (high blood pressure) and evaluating its combination effects.

Efficacy and Blood Pressure Reduction

Clinical trials involving the atenolol/chlorthalidone combination have consistently shown a significant reduction in both systolic and diastolic blood pressure in adults with mild to moderate hypertension. Key findings from controlled studies include:

  • Combination Effect: Research suggests the antihypertensive effects of atenolol and chlorthalidone are additive, meaning the combined use may lower blood pressure more effectively than either agent used alone at certain doses.
  • Duration of Action: Clinical data indicates that the blood pressure-lowering effect from a single daily dose may persist for at least 24 hours, supporting its once-daily administration.
  • Cardiovascular Outcomes: Lowering elevated blood pressure, often achieved with therapies like this combination, has been linked to a reduced risk of major cardiovascular events, particularly stroke and myocardial infarction (heart attack), in large-scale studies of hypertensive patients.

Safety and Tolerability Data

Safety analyses accompanying the efficacy trials have documented the occurrence of adverse events. The most commonly reported side effects across various studies include dizziness, fatigue, and nausea.

  • Metabolic Effects: As with all thiazide-type diuretics, the chlorthalidone component requires monitoring for potential effects on electrolyte balance (such as low potassium) and glucose levels.
  • Cardiovascular Risks: The atenolol component requires caution. Patients with pre-existing conditions like severe bradycardia (slow heart rate) or certain types of heart block were typically excluded from the treatment group in key clinical trials.

Key Studies & References DailyMed - TENORETIC- atenolol and chlorthalidone tablet (Source for drug monograph details)

Frequently Asked Questions (FAQ)

Common questions about Tenoretic 50 (FAQ)

Q: Do I need to take Tenoretic 50 forever once I start it?

Official product information states that Tenoretic 50 therapy should not be stopped suddenly. If discontinuation is necessary, the dosage is officially directed to be gradually reduced over a period of about one to two weeks, while the patient is monitored. This gradual reduction helps minimize the risk of serious side effects.

Q: Can Tenoretic 50 cause weight gain or weight loss?

Official regulatory documents do not list general weight change as a common side effect of Tenoretic 50. However, sudden or unusual weight gain is noted in some drug information as a signal that may require closer evaluation, as it can relate to serious conditions.

Q: Is it normal to feel more tired when starting Tenoretic 50?

Yes, it is common to feel more tired or lethargic when first starting this medication. Fatigue and lethargy are among the most frequently reported adverse reactions associated with the Atenolol component (the beta-blocker) of Tenoretic 50, according to regulatory documents.

Q: Does Tenoretic 50 affect blood sugar levels?

Yes, official safety information indicates that Tenoretic 50 can affect blood sugar. The diuretic component, Chlorthalidone, has been associated with increases in blood sugar (hyperglycemia). Additionally, the Atenolol component may mask the physical signs of acute low blood sugar (hypoglycemia), which is an important consideration for individuals with diabetes.

Q: Can Tenoretic 50 cause problems with sleep or insomnia?

Sleep-related problems are listed as a possible adverse reaction. Official reports note that sleep disturbances, including difficulty sleeping and vivid dreams or nightmares, have been reported by some users.

Q: Are there any over-the-counter pain relievers that interact with Tenoretic 50?

Official interaction information notes that Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which include many common over-the-counter pain relievers, may interfere with the blood pressure-lowering effect of Tenoretic 50. This potential interaction may decrease the effectiveness of the medication.

Q: Does Tenoretic 50 interact with coffee or caffeine?

Regulatory documents do not list a formal interaction between Tenoretic 50 and caffeine. However, the stimulant effects of caffeine (e.g., increased heart rate) could potentially oppose the intended effects of the beta-blocker component (Atenolol).

Q: Is it safe to drink alcohol in moderation while taking Tenoretic 50?

Alcohol may have additive effects with Tenoretic 50 in lowering blood pressure, according to official drug interaction profiles. This can increase the risk of side effects such as dizziness, lightheadedness, or fainting.

Q: Why is potassium important when taking a diuretic like the one in Tenoretic 50?

Potassium is a vital electrolyte necessary for proper muscle and heart function. The diuretic component (Chlorthalidone) can cause hypokalemia, or low potassium levels. Therefore, monitoring of potassium levels is required as part of a safe treatment protocol to address the potential for imbalance.

Q: Does Tenoretic 50 affect athletic performance or endurance?

Official reports indicate that common adverse reactions like fatigue, lethargy, and a slowed heart rate (bradycardia) may affect an individual's physical performance or endurance while taking this medication.

Q: Can I take multivitamins or supplements while on Tenoretic 50?

Official interaction guidance suggests that if a multivitamin containing minerals is taken, separating the administration time from Tenoretic 50 by at least two hours may be advised. This separation helps ensure the proper absorption and effectiveness of the medication.

Q: Is it true that Tenoretic 50 can cause cold hands and feet?

Yes, official reports classify cold extremities—specifically cold hands and feet—as a common adverse reaction. This effect is associated with the Atenolol component, the beta-blocker in the fixed-dose combination.

Q: Why do doctors often prescribe a combination pill like Tenoretic 50 instead of two separate pills?

Tenoretic 50 is a Fixed-Dose Combination (FDC) designed to offer a synergistic effect. This means the two components work together to provide a greater blood pressure-lowering effect than either medicine can achieve when used alone at comparable doses.

Q: Does Tenoretic 50 have any effect on cholesterol levels?

Official reports indicate that the diuretic component (Chlorthalidone) is associated with metabolic effects. These effects may include an increase in serum triglycerides and total cholesterol in some patients.

Q: What is the maximum effective duration of action for Tenoretic 50?

Clinical studies show that the blood pressure-lowering effect from a single daily dose of Tenoretic 50 can persist for at least 24 hours. This duration of action supports its once-daily administration schedule.

Q: Is Tenoretic 50 a first-line treatment for high blood pressure?

Official regulatory documents clearly state that the fixed-dose combination (FDC) is not indicated for the initial therapy of high blood pressure. It is typically reserved for use after the individual component dose requirements match the ratio found in the fixed-dose pill.

Q: Why are people often told not to stop Tenoretic 50 suddenly?

Stopping Tenoretic 50 abruptly is restricted because it may increase the risk of serious adverse effects. This includes the potential worsening of angina (chest pain) or, in rare cases, a myocardial infarction (heart attack).

Q: What are the symptoms of low potassium from the diuretic in Tenoretic 50?

Low potassium (hypokalemia) is a possible adverse reaction. Regulatory information indicates that symptoms can include muscle pain or cramps, unusual weakness, fatigue, or a fast or irregular heartbeat.

Q: Does Tenoretic 50 affect male sexual health?

Official reports list certain adverse reactions related to sexual health. These include decreased sexual ability, a change in sex drive or performance, and impotence.

Q: Can a person develop a tolerance to Tenoretic 50 over time?

According to official pharmacological data, clinical studies have not shown a diminution (decrease) in the antihypertensive effectiveness of the Atenolol component, the beta-blocker, even with prolonged use.

Q: How should Tenoretic 50 be stored to keep it effective?

To help maintain effectiveness, Tenoretic 50 tablets must be stored at controlled room temperature, typically at or below 25 C. They should be kept protected from light and moisture and remain in the original, tightly closed container.

Q: Do people with kidney issues need to take a different dose of Tenoretic 50?

Yes, official dosing guidelines direct that the dosage should be adjusted if an individual has significant renal impairment. This is especially true when creatinine clearance (a measure of kidney function) falls below a specific threshold.

Q: Can I take Tenoretic 50 if I have a history of gout?

The diuretic component, Chlorthalidone, may potentially cause high uric acid levels (hyperuricemia) or trigger acute gout in certain patients. Regulatory warnings indicate that caution may be necessary in this context.

Q: Does Tenoretic 50 make you feel dehydrated?

The diuretic component works by increasing the urinary excretion of salt and water. Official drug information sources list symptoms of dehydration, such as increased thirst and dry mouth, as possible adverse reactions.

Q: Is it necessary to have routine blood tests while on Tenoretic 50?

Official regulatory warnings recommend routine monitoring. Due to the metabolic effects of the diuretic component, monitoring of important body salts (electrolyte status) and blood glucose levels is often required as part of the treatment protocol.

Q: Does Tenoretic 50 interact with nasal decongestants?

Official interaction documents warn that combining Tenoretic 50 with sympathomimetic agents (like those found in many nasal decongestants) may lead to a potentially significant increase in blood pressure.

Q: What is the role of Tenoretic 50 in treating angina?

While Tenoretic 50 is primarily indicated for hypertension, the Atenolol component is also indicated for the long-term management of angina pectoris (chest pain). Its role is to help reduce the heart's oxygen requirement.

Q: Can Tenoretic 50 cause leg cramps?

Yes, muscle cramps or pain, particularly leg cramps, are listed as a symptom associated with low potassium (hypokalemia). Low potassium is a known adverse effect caused by the diuretic component of Tenoretic 50.

Q: Is it possible to take Tenoretic 50 with other blood pressure medications?

Yes, it is possible, but specific rules apply. Official interaction documents highlight certain contraindicated combinations, such as administering intravenous Verapamil or Diltiazem near the time of taking Tenoretic 50.

Q: Why do some people experience blurred vision with Tenoretic 50?

Blurred vision is listed as an adverse reaction in the official safety profile. This effect may be related to the drug's effect on blood pressure or may be a sign of another underlying condition.

Q: Are there any long-term effects of taking Tenoretic 50 for many years?

Official safety information highlights that continuous monitoring is necessary for long-term use. This monitoring is required for electrolyte status and blood glucose levels due to the known metabolic effects of the diuretic component.

How should Tenoretic 50 be stored and disposed of?

How to Store and Dispose of Tenoretic 50

Official Storage Requirements

Tenoretic 50 tablets must be stored at controlled room temperature, specifically at or below 25°C or between 15°C to 25°C. The medication requires protection from light and moisture and should be kept away from excess heat. The tablets must remain in the original container, tightly closed, with blister packs stored in the outer carton.

Child Safety and Disposal

As a mandatory safety measure, Tenoretic 50 must be kept out of the sight and reach of children at all times. The medication should not be used past its labeled expiry date.

Regarding disposal, unused or expired product must be discarded in an appropriate way. Official sources indicate there are no special requirements for disposal beyond general regulations, but the medication should not be discarded in the bathroom or flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Tenoretic 50 found in:

A-Z Index: